Both in Biotechnology
Fate Therapeutics vs Cabaletta Bio
Over the past year FATE returned +64.3% and CABA returned −52.3%; their daily moves had a correlation of 0.46.
FATE +64.3% CABA −52.3%Growth of $1, one year, split-adjusted
| Metric | FATE | CABA |
|---|---|---|
| Price | $2.07 | $1.44 |
| Market cap | $248.0M | $243.3M |
| Today | +1.47% | +1.06% |
| 1 month | −9.6% | −29.0% |
| 6 months | −9.6% | −61.5% |
| Year to date | +110.7% | −34.5% |
| 1 year | +64.3% | −52.3% |
| Revenue growth (YoY) | +9.2% | — |
| Gross margin | 100.0% | — |
| Net margin | −1448.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 38.2× | — |
| Net cash | $153.8M | $205.1M |
| Dividend yield | — | — |
| Volatility (60d) | 56.3% | 78.8% |
| Short % of float | 10.4% | 27.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).